Management of inflammatory bowel disease in pregnancy

Expert Review of Clinical Immunology

Volumn 9, Issue 2, 2013, Pages 161-174

  Ng, Susie W ^a   Mahadevan, Uma ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

inflammatory bowel disease; infliximab; pregnancy; thiopurines; ulcerative colitis

Indexed keywords

ADALIMUMAB; AMOXICILLIN PLUS CLAVULANIC ACID; AZATHIOPRINE; BALSALAZIDE; BUDESONIDE; CERTOLIZUMAB PEGOL; CIPROFLOXACIN; CYCLOSPORIN; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; NATALIZUMAB; OLSALAZINE; PREDNISONE; RIFAXIMIN; SALAZOSULFAPYRIDINE; TACROLIMUS; THALIDOMIDE;

BREAST FEEDING; CONCEPTION; DISEASE ACTIVITY; ENTERITIS; FERTILITY; HERITABILITY; HUMAN; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT MONITORING; PREGNANCY; PREGNANCY OUTCOME; PUERPERIUM; REVIEW;

ANIMALS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; INFLAMMATORY BOWEL DISEASES; MEDICATION ADHERENCE; METHOTREXATE; MONITORING, PHYSIOLOGIC; PREGNANCY; PREGNANCY COMPLICATIONS; RISK ASSESSMENT;

EID: 84873894964     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.12.103     Document Type: Review

References (113)

1. Kwan LY, Mahadevan U. Inflammatory bowel disease and pregnancy: An update. Expert Rev. Clin. Immunol. 6(4), 643-657 (2010
2. Orholm M, Fonager K, Sørensen HT. Risk of ulcerative colitis and Crohn's disease among offspring of patients with chronic inflammatory bowel disease. Am. J. Gastroenterol. 94(11), 3236-3238 (1999
3. Yang H, McElree C, Roth MP, Shanahan F, Targan SR, Rotter JI. Familial empirical risks for inflammatory bowel disease: Differences between Jews and non-Jews. Gut 34(4), 517-524 (1993
4. Bennett RA, Rubin PH, Present DH. Frequency of inflammatory bowel disease in offspring of couples both presenting with inflammatory bowel disease. Gastroenterology 100(6), 1638-1643 (1991
5. Laharie D, Debeugny S, Peeters M et al. Inflammatory bowel disease in spouses and their offspring. Gastroenterology 120(4), 816-819 (2001
6. Malmborg P, Bahmanyar S, Grahnquist L, Hildebrand H, Montgomery S. Cesarean section and the risk of pediatric Crohn's disease. Inflamm. Bowel Dis. 18(4), 703-708 (2012
7. Bager P, Simonsen J, Nielsen NM, Frisch M. Cesarean section and offspring's risk of inflammatory bowel disease: A national cohort study. Inflamm. Bowel Dis. 18(5), 857-862 (2012
8. Hudson M, Flett G, Sinclair TS, Brunt PW, Templeton A, Mowat NA. Fertility and pregnancy in inflammatory bowel disease. Int. J. Gynaecol. Obstet. 58(2), 229-237 (1997
9. Nielsen OH, Andreasson B, Bondesen S, Jarnum S. Pregnancy in ulcerative colitis. Scand. J. Gastroenterol. 18(6), 735-742 (1983
10. Bajocco PJ, Korelitz BJ. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J. Clin. Gastroenterol. 6, 211-216 (1984
11. Fielding JF, Cooke WT. Pregnancy and Crohn's disease. BMJ 2(5701), 76-77 (1970
12. Timmer A, Bauer A, Dignass A, Rogler G. Sexual function in persons with inflammatory bowel disease: A survey with matchedeview controls. Clin. Gastroenterol. Hepatol. 5(1), 87-94 (2007
13. Winger EE, Reed JL, Ashoush S, Ahuja S, El-Toukhy T, Taranissi M. Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am. J. Reprod. Immunol. 61(2), 113-120 (2009
14. Ørding Olsen K, Juul S, Berndtsson I, Oresland T, Laurberg S. Ulcerative colitis: Female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology 122(1), 15-19 (2002
15. Johnson P, Richard C, Ravid A et al. Female infertility after ileal pouch-anal anastomosis for ulcerative colitis. Dis. Colon Rectum 47(7), 1119-1126 (2004
16. Waljee A, Waljee J, Morris AM, Higgins PD. Threefold increased risk of infertility: A meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut 55(11), 1575-1580 (2006
17. Rajaratnam SG, Eglinton TW, Hider P, Fearnhead NS. Impact of ileal pouch-anal anastomosis on female fertility: Meta-analysis and systematic review. Int. J. Colorectal Dis. 26(11), 1365-1374 (2011
18. Mortier PE, Gambiez L, Karoui M et al. Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis. Gastroenterol. Clin. Biol. 30(4), 594-597 (2006
19. Indar AA, Efron JE, Young-Fadok TM. Laparoscopic ileal pouch-anal anastomosis reduces abdominal and pelvic adhesions. Surg. Endosc. 23(1), 174-177 (2009
20. Bartels SA, Vlug MS, Henneman D, Ponsioen CY, Tanis PJ, Bemelman WA. Less adhesiolysis and hernia repair during completion proctocolectomy after laparoscopic emergency colectomy for ulcerative colitis. Surg. Endosc. 26(2), 368-373 (2012
21. Levi AJ, Fisher AM, Hughes L, Hendry WF. Male infertility due to sulphasalazine. Lancet 2(8137), 276-278 (1979
22. Birnie GG, McLeod TI, Watkinson G. Incidence of sulphasalazine-induced male infertility. Gut 22(6), 452-455 (1981
23. O'Moráin C, Smethurst P, Doré CJ, Levi AJ. Reversible male infertility due to sulphasalazine: Studies in man and rat. Gut 25(10), 1078-1084 (1984
24. Toth A. Reversible toxic effect of salicylazosulfapyridine on semen quality. Fertil. Steril. 31(5), 538-540 (1979
25. Toovey S, Hudson E, Hendry WF, Levi AJ. Sulphasalazine and male infertility: Reversibility and possible mechanism. Gut 22(6), 445-451 (1981
26. Dejaco C, Mittermaier C, Reinisch W et al. Azathioprine treatment and male fertility in inflammatory bowel disease. Gastroenterology 121(5), 1048-1053 (2001
27. French AE, Koren G; Motherisk Team. Effect of methotrexate on male fertility. Can. Fam. Physician 49, 577-578 (2003
28. Nielsen OH, Andreasson B, Bondesen S, Jacobsen O, Jarnum S. Pregnancy in Crohn's disease. Scand. J. Gastroenterol. 19(6), 724-732 (1984
29. Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA. Pregnancy outcomes in women with inflammatory bowel disease: A large community-based study from Northern California. Gastroenterology 133(4), 1106-1112 (2007
30. Khosla R, Willoughby CP, Jewell DP. Crohn's disease and pregnancy. Gut 25(1), 52-56 (1984
31. Willoughby CP, Truelove SC. Ulcerative colitis and pregnancy. Gut 21(6), 469-474 (1980
32. Friedman S. Medical therapy and birth outcomes in women with Crohn's disease: What should we tell our patients? Am. J. Gastroenterol. 102(7), 1414-1416 (2007
33. Katz JA, Pore G. Inflammatory bowel disease and pregnancy. Inflamm. Bowel Dis. 7(2), 146-157 (2001
34. Miller JP. Inflammatory bowel disease in pregnancy: A review. J. R. Soc. Med. 79(4), 221-225 (1986
35. Ujihara M, Ando T, Ishiguro K et al. Appropriate pharmaceutical management is crucial for pregnant women complicated by ulcerative colitis. Presented at: Digestive Disease Week. San Diego, CA, USA, 19-22 May 2012
36. Unger JA, Whimbey E, Gravett MG, Eschenbach DA. The emergence of Clostridium difficile infection among peripartum women: A case-control study of a C. difficile outbreak on an obstetrical service. Infect. Dis. Obstet. Gynecol. 2011, 267249 (2011
37. Reddy D, Murphy SJ, Kane SV, Present DH, Kornbluth AA. Relapses of inflammatory bowel disease during pregnancy: In-hospital management and birth outcomes. Am. J. Gastroenterol. 103(5), 1203-1209 (2008
38. Cornish J, Tan E, Teare J et al. A metaanalysis on the influence of inflammatory bowel disease on pregnancy. Gut 56(6), 830-837 (2007
39. Nguyen GC, Boudreau H, Harris ML, Maxwell CV. Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States. Clin. Gastroenterol. Hepatol. 7(3), 329-334 (2009
40. Stephansson O, Larsson H, Pedersen L et al. Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden. Inflamm. Bowel Dis. 17(3), 795-801 (2011
41. Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease - a populationbased cohort study. Am. J. Obstet. Gynecol. 177(4), 942-946 (1997
42. Ilnyckyj A, Bernstein CN. Perianal Crohn's disease: Role of mode of delivery. Am. J. Gastroenterol. 94(11), 3274-3278 (1999
43. Beniada A, Benoist G, Maurel J, Dreyfus M. Inflammatory bowel disease and pregnancy: Report of 76 cases and review of the literature. J. Gynecol. Obstet. Biol. Reprod. (Paris) 34(6), 581-588 (2005
44. Ravid A, Richard CS, Spencer LM et al. Pregnancy, delivery, and pouch function after ileal pouch-anal anastomosis for ulcerative colitis. Dis. Colon Rectum 45(10), 1283-1288 (2002
45. Kitayama T, Funayama Y, Fukushima K et al. Anal function during pregnancy and postpartum after ileal pouch anal anastomosis for ulcerative colitis. Surg. Today 35(3), 211-215 (2005
46. Nørgård B, Fonager K, Sørensen HT, Olsen J. Birth outcomes of women with ulcerative colitis: A nationwide Danish cohort study. Am. J. Gastroenterol. 95(11), 3165-3170 (2000
47. Fonager K, Sørensen HT, Olsen J, Dahlerup JF, Rasmussen SN. Pregnancy outcome for women with Crohn's disease: A follow-up study based on linkage between national registries. Am. J. Gastroenterol. 93(12), 2426-2430 (1998
48. Dominitz JA, Young JC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: A populationbased cohort study. Am. J. Gastroenterol. 97(3), 641-648 (2002
49. Stephansson O, Larsson H, Pedersen L et al. Crohn's disease is a risk factor for preterm birth. Clin. Gastroenterol. Hepatol. 8(6), 509-515 (2010
50. Molnár T, Farkas K, Nagy F et al. Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: A case-control study. Scand. J. Gastroenterol. 45(11), 1302-1306 (2010
51. Bortoli A, Pedersen N, Duricova D et al.; European Crohn-Colitis Organisation (ECCO) Study Group of Epidemiologic Committee (EpiCom). Pregnancy outcome in inflammatory bowel disease: Prospective European case-control ECCO-EpiCom study, 2003-2006. Aliment. Pharmacol. Ther. 34(7), 724-734 (2011
52. Morales M, Berney T, Jenny A, Morel P, Extermann P. Crohn's disease as a risk factor for the outcome of pregnancy. Hepatogastroenterology. 47(36), 1595-1598 (2000
53. Bush MC, Patel S, Lapinski RH, Stone JL. Perinatal outcomes in inflammatory bowel disease. J. Matern. Fetal. Neonatal. Med. 15(4), 237-241 (2004
54. Fedorkow DM, Persaud D, Nimrod CA. Inflammatory bowel disease: A controlled study of late pregnancy outcome. Am. J. Obstet. Gynecol. 160(4), 998-1001 (1989
55. Nørgård B, Hundborg HH, Jacobsen BA, Nielsen GL, Fonager K. Disease activity in pregnant women with Crohn's disease and birth outcomes: A regional Danish cohort study. Am. J. Gastroenterol. 102(9), 1947-1954 (2007
56. Moser MA, Okun NB, Mayes DC, Bailey RJ. Crohn's disease, pregnancy, and birth weight. Am. J. Gastroenterol. 95(4), 1021-1026 (2000
57. Bengtson MB, Solberg IC, Aamodt G, Jahnsen J, Moum B, Vatn MH; IBSEN Study Group. Relationships between inflammatory bowel disease and perinatal factors: Both maternal and paternal disease are related to preterm birth of offspring. Inflamm. Bowel Dis. 16(5), 847-855 (2010
58. Kane S, Lemieux N. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am. J. Gastroenterol. 100(1), 102-105 (2005
59. Moffatt DC, Ilnyckyj A, Bernstein CN. A population-based study of breastfeeding in inflammatory bowel disease: Initiation, duration, and effect on disease in the postpartum period. Am. J. Gastroenterol. 104(10), 2517-2523 (2009
60. Gilat T, Hacohen D, Lilos P, Langman MJ. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand. J. Gastroenterol. 22(8), 1009-1024 (1987
61. Baron S, Turck D, Leplat C et al. Environmental risk factors in paediatric inflammatory bowel diseases: A population based case control study. Gut 54(3), 357-363 (2005
62. Barclay AR, Russell RK, Wilson ML, Gilmour WH, Satsangi J, Wilson DC. Systematic review: The role of breastfeeding in the development of pediatric inflammatory bowel disease. J. Pediatr. 155(3), 421-426 (2009
63. Mahadevan U, Martin C, Sandler RS et al. PIANO: A 1000 patient prospective registry of pregnancy outcomes in women with IBD exposed to immunomodulators and biologic therapy. Gastroenterology 142(5 Suppl. 1), S149 (2012) (Abstract
64. Asacol (mesalamine), package insert. Warner Chilcott Pharmaceuticals Inc., OH, USA (2010
65. Hernández-Díaz S, Mitchell AA, Kelley KE, Calafat AM, Hauser R. Medications as a potential source of exposure to phthalates in the U.S. population. Environ. Health Perspect. 117(2), 185-189 (2009
66. Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: A meta-analysis. Reprod. Toxicol. 25(2), 271-275 (2008
67. Colombel JF, Brabant G, Gubler MC et al Renal insufficiency in infant: Side-effect of prenatal exposure to mesalazine? Lancet 344(8922), 620-621 (1994
68. Esbjörner E, Järnerot G, Wranne L. Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation. Acta Paediatr. Scand. 76(1), 137-142 (1987
69. Nelis GF. Diarrhoea due to 5-aminosalicylic acid in breast milk. Lancet 1(8634), 383 (1989
70. Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. Am. J. Med. Genet. 86(3), 242-244 (1999
71. Park-Wyllie L, Mazzotta P, Pastuszak A et al. Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies. Teratology 62(6), 385-392 (2000
72. Beaulieu DB, Ananthakrishnan AN, Issa M et al. Budesonide induction and maintenance therapy for Crohn's disease during pregnancy. Inflamm. Bowel Dis. 15(1), 25-28 (2009
73. Ost L, Wettrell G, Björkhem I, Rane A. Prednisolone excretion in human milk. J. Pediatr. 106(6), 1008-1011 (1985
74. McKenzie SA, Selley JA, Agnew JE. Secretion of prednisolone into breast milk. Arch. Dis. Child. 50(11), 894-896 (1975
75. Greenberger PA, Odeh YK, Frederiksen MC, Atkinson AJ Jr. Pharmacokinetics of prednisolone transfer to breast milk. Clin. Pharmacol. Ther. 53(3), 324-328 (1993
76. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: A meta-analysis. Am. J. Obstet. Gynecol. 172(2 Pt 1), 525-529 (1995
77. Caro-Patón T, Carvajal A, Martin de Diego I, Martin-Arias LH, Alvarez Requejo A, Rodríguez Pinilla E. Is metronidazole teratogenic? A meta-analysis. Br. J. Clin. Pharmacol. 44(2), 179-182 (1997
78. Piper JM, Mitchel EF, Ray WA. Prenatal use of metronidazole and birth defects: No association. Obstet. Gynecol. 82(3), 348-352 (1993
79. Diav-Citrin O, Shechtman S, Gotteiner T, Arnon J, Ornoy A. Pregnancy outcome after gestational exposure to metronidazole: A prospective controlled cohort study. Teratology 63(5), 186-192 (2001
80. Czeizel AE, Rockenbauer M. A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br. J. Obstet. Gynaecol. 105(3), 322-327 (1998
81. Loebstein R, Addis A, Ho E et al. Pregnancy outcome following gestational exposure to fluoroquinolones: A multicenter prospective controlled study. Antimicrob. Agents Chemother. 42(6), 1336-1339 (1998
82. Polifka JE, Friedman JM. Teratogen update: Azathioprine and 6-mercaptopurine. Teratology 65(5), 240-261 (2002
83. Nørgård B, Pedersen L, Fonager K, Rasmussen SN, Sørensen HT. Azathioprine, mercaptopurine and birth outcome: A population-based cohort study. Aliment. Pharmacol. Ther. 17(6), 827-834 (2003
84. Goldstein LH, Dolinsky G, Greenberg R et al. Pregnancy outcome of women exposed to azathioprine during pregnancy. Birth Defects Res. Part A Clin. Mol. Teratol. 79(10), 696-701 (2007
85. Cleary BJ, Källén B. Early pregnancy azathioprine use and pregnancy outcomes. Birth Defects Res. Part A Clin. Mol. Teratol. 85(7), 647-654 (2009
86. Coelho J, Beaugerie L, Colombel JF et al.; CESAME Pregnancy Study Group (FrancePregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: Cohort from the CESAME Study. Gut 60(2), 198-203 (2011
87. Hoeltzenbein M, Weber-Schoendorfer C, Borisch C, Allignol A, Meister R, Schaefer C. Pregnancy outcome after paternal exposure to azathioprine/6- mercaptopurine. Reprod. Toxicol. 34(3), 364-369 (2012
88. Christensen LA, Dahlerup JF, Nielsen MJ, Fallingborg JF, Schmiegelow K. Azathioprine treatment during lactation. Aliment. Pharmacol. Ther. 28(10), 1209-1213 (2008
89. Sau A, Clarke S, Bass J, Kaiser A, Marinaki A, Nelson-Piercy C Azathioprine and breastfeeding: Is it safe? BJOG 114(4), 498-501 (2007
90. Moretti ME, Verjee Z, Ito S, Koren G. Breast-feeding during maternal use of azathioprine. Ann. Pharmacother. 40(12), 2269-2272 (2006
91. Methotrexate sodium, package insert. Teva Pharmaceuticals, PA, USA (2011
92. Beghin D, Cournot MP, Vauzelle C, Elefant E. Paternal exposure to methotrexate and pregnancy outcomes. J. Rheumatol. 38(4), 628-632 (2011
93. Johns DG, Rutherford LD, Leighton PC, Vogel CL. Secretion of methotrexate into human milk. Am. J. Obstet. Gynecol. 112(7), 978-980 (1972
94. Ostensen M, Lockshin M, Doria A et al. Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. Rheumatology 47(Suppl. 3), iii28-31 (2008
95. Kainz A, Harabacz I, Cowlrick IS, Gadgil SD, Hagiwara D. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation 70(12), 1718-1721 (2000
96. Perales-Puchalt A, Vila Vives JM, López Montes J, Diago Almela VJ, Perales A. Pregnancy outcomes after kidney transplantation-immunosuppressive therapy comparison. J. Matern. Fetal. Neonatal. Med. 25(8), 1363-1366 (2012
97. Baumgart DC, Sturm A, Wiedenmann B, Dignass AU. Uneventful pregnancy and neonatal outcome with tacrolimus in refractory ulcerative colitis. Gut 54(12), 1822-1823 (2005
98. Simister NE Placental transport of immunoglobulin G. Vaccine 21(24), 3365-3369 (2003
99. Cheent K, Nolan J, Shariq S, Kiho L, Pal A, Arnold J. Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J. Crohns. Colitis 4(5), 603-605 (2010
100. Lichtenstein G, Cohen RD, Feagan BG et al. Safety of infliximab in Crohn's disease: Data from the 5000-patient TREAT Registry. Gastroenterology 126(Suppl. 4), A54 (2004
101. Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am. J. Gastroenterol. 99(12), 2385-2392 (2004
102. Mahadevan U, Kane S, Sandborn WJ et al. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment. Pharmacol. Ther. 21(6), 733-738 (2005
103. Schnitzler F, Fickler HH, Ferrante M et al. Intentional treatment with infliximab during pregnancy in women with inflammatory bowel disease. Gastroenterology 132(4), A144-A144 (2007
104. Schnitzler F, Fidder H, Ferrante M et al. Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy. Inflamm. Bowel Dis. 17(9), 1846-1854 (2011
105. Carter JD, Ladhani A, Ricca LR, Valeriano J, Vasey FB. A safety assessment of tumor necrosis factor antagonists during pregnancy: A review of the Food and Drug Administration database. J. Rheumatol. 36(3), 635-641 (2009
106. Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinsky MC. Case report: Evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin. Gastroenterol. Hepatol. 4(10), 1255-1258 (2006
107. Ben-Horin S, Yavzori M, Kopylov U et al. Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease. J. Crohns. Colitis 5(6), 555-558 (2011
108. Jürgens M, Brand S, Filik L et al. Safety of adalimumab in Crohn's disease during pregnancy: Case report and review of the literature. Inflamm. Bowel Dis. 16(10), 1634-1636 (2010
109. Ben-Horin S, Yavzori M, Katz L et al. Adalimumab level in breast milk of a nursing mother. Clin. Gastroenterol. Hepatol. 8(5), 475-476 (2010
110. Nesbitt A, Brown D, Stephens S, Foulkes R Placental transfer and accumulation in milk of the anti-TNF antibody TN3 in rats: Immunoglobulin G1 versus PEGylated Fab'. Am. J. Gastroenterol. Abstract 119 (2006
111. Wolf D, Mahadevan U. Certolizumab pegol use in pregnancy: Low levels detected in cord blood. [abstract]. Arthritis Rheum. 62(Suppl. 10), 718 (2010
112. Hellwig K, Haghikia A, Gold R. Pregnancy and natalizumab: Results of an observational study in 35 accidental pregnancies during natalizumab treatment. Mult. Scler. 17(8), 958-963 (2011
113. Nazareth M, Hogge GS, Cristiano L, Kooijmans M, Mahadevan U. Natalizumab use during pregnancy. Presented at: Annual Meeting of the American College of Gastroenterology. Orlando, FL, USA, 3-8 October 2008)